- Net Loss of $493 million and $775 million and Return on Equity of (9.8)% and (13.9)% for the three and six months ended June 30, 2022, driven by unrealized losses on fixed income securities in the rising interest rate environment
- Book Value per Ordinary Share and Adjusted Book Value per Ordinary Share* of $245.93 and $241.05, respectively, as of June 30, 2022
- Returned $163 million to shareholders through share repurchases at a weighted average discount to book value of 20.3% during the six months ended June 30, 2022
- Agreed a Loss Portfolio Transfer with Argo Group International Holdings, Ltd. (“Argo”) covering a number of Argo’s U.S. casualty insurance portfolios, with a policy limit of $1.1 billion
HAMILTON, Bermuda, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Enstar Group Limited (Nasdaq: ESGR) filed its quarterly report on Form 10-Q with the SEC earlier today. An audio presentation reviewing the second quarter 2022 results with expanded commentary is available on Enstar's investor relations website at investor.enstargroup.com.
Second Quarter 2022 Highlights:
- Return on equity ("ROE") of (9.8)% and Adjusted ROE* of (2.9)% compared to 6.0% and 5.1%, respectively, in the second quarter 2021. ROE was impacted by $379 million of net unrealized losses arising from interest rate increases on fixed maturity portfolios that are classified as trading, combined with $212 million of net unrealized losses in Enstar's non-core portfolios.
- The market dislocation has resulted in material unrealized losses in our investment portfolio impacted by the combination of interest rate increases, widening credit spreads and equity market declines. While we recognized net investment losses of $522 million in the quarter, we are confident in our investment strategies for the long term.
- Positively, our solvency or economic balance sheet became stronger during the second quarter. This is driven by two factors:
- First, our solvency ratio reflects not only losses on investments but also the impact of a higher discount rate on our reserves; and
- Secondly, our core fixed income securities are shorter in duration than our insurance liabilities.
- Our quarter's run-off liability earnings ("RLE") benefited from reductions in the value of certain portfolios that are held at fair value and favorable loss activity in the professional indemnity/directors and officers and workers' compensation lines of business net of amortization of deferred charge assets ("DCAs").
- On August 8, 2022, we executed an LPT agreement with a wholly owned subsidiary of Argo covering a number of its U.S. casualty insurance portfolios, including construction, for accident years 2011 to 2019. We will provide ground up cover of $746 million, and an additional $275 million of cover in excess of $821 million, up to a policy limit of $1.1 billion. Argo will retain a loss corridor of $75 million up to $821 million. The closing of the transaction is subject to regulatory approval and other closing conditions which we expect to be completed in the second half of 2022.
* Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for explanatory notes and a reconciliation to the most directly comparable GAAP measure.
Commenting on the Company’s results, Enstar CEO Dominic Silvester said:
“We completed one of our largest-ever loss portfolio transactions in the quarter, assuming an incremental $1.9 billion of subject loss reserves from Aspen, an established business partner, and transitioned claims management authority to Enstar. In addition, on August 8, 2022, we announced a reinsurance agreement with Argo which will provide us with the opportunity to bring our legacy expertise to the run-off of Argo’s US casualty book.
Our second quarter financial results continued to be impacted by unrealized investment losses, resulting from rising interest rates and ongoing economic uncertainty. Our fixed income portfolio has incurred a significant amount of the unrealized losses. However, it is important to keep in mind that this portfolio is designed to largely complement the maturity of underlying loss reserves and as such, we expect the losses to unwind over time. Overall, we remain confident that our investment strategy can generate strong value for the long term. We maintain a strong balance sheet with capacity to continue to pursue our active pipeline of opportunities and remain focused on delivering long-term value to our partners and shareholders.
We are seeing a robust market demand for our solutions and we maintain discipline with respect to acquiring new business and will only execute on transactions where we can generate appropriate risk-adjusted returns.”
Six months ended results included:
- Net loss of $775 million, or $44.54 per diluted ordinary share, compared to net earnings of $561 million, or $25.60 per diluted ordinary share, for the six months ended June 30, 2021.
- ROE of (13.9)% and Adjusted ROE* of (4.2)%, compared to 9.1% and 10.9%, respectively, for the six months ended June 30, 2021. ROE was impacted by unrealized losses arising from interest rate increases on fixed maturity portfolios that are classified trading combined with unrealized losses in Enstar's non-core portfolios.
- Annualized RLE of 3.7% and Annualized Adjusted RLE* of 0.5%, compared to 2.5% and 1.1%, respectively, for the six months ended June 30, 2021. RLE benefited from reductions in the value of certain portfolios that are held at fair value, favorable loss activity in the professional indemnity/directors and officers and workers' compensation lines of business net of amortization of DCAs, and favorable results on Enstar's inactive catastrophe programs held by Enhanzed Re.
- Annualized total investment return ("TIR") of (8.1)% and Annualized Adjusted TIR* of (0.8)%, compared to 6.8% and 8.0%, respectively, for the six months ended June 30, 2021. Recognized investment results were impacted by the combination of interest rate increases, widening credit spreads and equity market declines.
- We repurchased 697,580 voting ordinary shares during the six months ended June 30, 2022 for an aggregate $163 million, representing an average price per share of $233.92 and a weighted average discount to our net book value per ordinary share of 20.3%. During the six months ended June 30, 2022, we utilized $105 million of the $200 million authorized under the 2022 Repurchase Program and the remaining $59 million authorized under the 2021 Repurchase Program to repurchase our ordinary shares.
* Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for explanatory notes and a reconciliation to the most directly comparable GAAP measure.
Key Financial and Operating Metrics
We use the following GAAP and Non-GAAP measures to monitor the performance of and manage the company:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| June 30, 2022 | June 30, 2021 | $ / pp / bp Change | June 30, 2022 | June 30, 2021 | $ / pp / bp Change | ||||||||||||||||||
| (in millions of U.S. dollars, except per share data) | |||||||||||||||||||||||
| Key Earnings Metrics | |||||||||||||||||||||||
| Net (loss) earnings attributable to Enstar ordinary shareholders | $ | (493 | ) | $ | 378 | $ | (871 | ) | $ | (775 | ) | $ | 561 | $ | (1,336 | ) | |||||||
| Adjusted operating (loss) income attributable to Enstar ordinary shareholders* | $ | (150 | ) | $ | 296 | $ | (446 | ) | $ | (223 | ) | $ | 591 | $ | (814 | ) | |||||||
| ROE | (9.8 | )% | 6.0 | % | (15.8 | )pp | (13.9 | )% | 9.1 | % | (23.0 | )pp | |||||||||||
| Annualized ROE | (27.7 | )% | 18.2 | % | (45.9 | )pp | |||||||||||||||||
| Adjusted ROE* | (2.9 | )% | 5.1 | % | (8.0 | )pp | (4.2 | )% | 10.9 | % | (15.1 | )pp | |||||||||||
| Annualized Adjusted ROE* | (8.4 | )% | 21.7 | % | (30.1 | )pp | |||||||||||||||||
| Key Run-off Metrics | |||||||||||||||||||||||
| Prior period development | $ | 79 | $ | 10 | $ | 69 | $ | 222 | $ | 120 | $ | 102 | |||||||||||
| Adjusted prior period development* | $ | 29 | $ | 24 | $ | 5 | $ | 28 | $ | 50 | $ | (22 | ) | ||||||||||
| Annualized RLE | 3.7 | % | 2.5 | % | 1.2 | pp | |||||||||||||||||
| Annualized Adjusted RLE* | 0.5 | % | 1.1 | % | (0.6 | )pp | |||||||||||||||||
| Key Investment Return Metrics | |||||||||||||||||||||||
| Total investable assets | $ | 20,869 | $ | 20,169 | $ | 700 | |||||||||||||||||
| Adjusted total investable assets* | $ | 22,115 | $ | 19,830 | $ | 2,285 | |||||||||||||||||
| Annualized investment book yield | 2.32 | % | 2.65 | % | (33 | )bp | 2.03 | % | 2.24 | % | (21 | )bp | |||||||||||
| Annualized TIR | (8.1 | )% | 6.8 | % | (14.9 | )pp | |||||||||||||||||
| Annualized Adjusted TIR* | (0.8 | )% | 8.0 | % | (8.8 | )pp | |||||||||||||||||
| As of | |||||||||||||||||||||||
| June 30, 2022 | December 31, 2021 | ||||||||||||||||||||||
| Key Shareholder Metrics | |||||||||||||||||||||||
| Book value per ordinary share | $ | 245.93 | $ | 316.34 | $ | (70.41 | ) | ||||||||||||||||
| Adjusted book value per ordinary share* | $ | 241.05 | $ | 310.80 | $ | (69.75 | ) | ||||||||||||||||
pp - Percentage point(s)
bp - Basis point(s)
* Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for explanatory notes and a reconciliation to the most directly comparable GAAP measure.
Results of Operations by Segment - For the Three and Six Months Ended June 30, 2022 and 2021
Run-off Segment
The following is a discussion and analysis of the results of operations for our Run-off segment.
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| June 30, | $ | June 30, | $ | ||||||||||||||||||||
| 2022 | 2021 | Change | 2022 | 2021 | Change | ||||||||||||||||||
| INCOME | (in millions of U.S. dollars) | ||||||||||||||||||||||
| Net premiums earned | $ | 9 | $ | 42 | $ | (33 | ) | $ | 26 | $ | 115 | $ | (89 | ) | |||||||||
| Other income: | |||||||||||||||||||||||
| Reduction in estimates of net ultimate defendant A&E liabilities - prior periods | 1 | 5 | (4 | ) | 4 | 14 | (10 | ) | |||||||||||||||
| Reduction in estimated future defendant A&E expenses | 1 | — | 1 | 1 | 3 | (2 | ) | ||||||||||||||||
| All other income | 5 | 9 | (4 | ) | 12 | 19 | (7 | ) | |||||||||||||||
| Total other income | 7 | 14 | (7 | ) | 17 | 36 | (19 | ) | |||||||||||||||
| Total income | 16 | 56 | (40 | ) | 43 | 151 | (108 | ) | |||||||||||||||
| EXPENSES | |||||||||||||||||||||||
| Net incurred losses and LAE: | |||||||||||||||||||||||
| Current period | 14 | 42 | (28 | ) | 25 | 86 | (61 | ) | |||||||||||||||
| Prior periods: | |||||||||||||||||||||||
| Reduction in estimates of net ultimate losses | (108 | ) | (42 | ) | (66 | ) | (137 | ) | (67 | ) | (70 | ) | |||||||||||
| Reduction in provisions for ULAE | (13 | ) | (17 | ) | 4 | (34 | ) | (31 | ) | (3 | ) | ||||||||||||
| Total prior periods | (121 | ) | (59 | ) | (62 | ) | (171 | ) | (98 | ) | (73 | ) | |||||||||||
| Total net incurred losses and LAE | (107 | ) | (17 | ) | (90 | ) | (146 | ) | (12 | ) | (134 | ) | |||||||||||
| Acquisition costs | 9 | — | 9 | 17 | 29 | (12 | ) | ||||||||||||||||
| General and administrative expenses (1) | 36 | 64 | (28 | ) | 75 | 92 | (17 | ) | |||||||||||||||
| Total expenses | (62 | ) | 47 | (109 | ) | (54 | ) | 109 | (163 | ) | |||||||||||||
| SEGMENT NET EARNINGS | $ | 78 | $ | 9 | $ | 69 | $ | 97 | $ | 42 | $ | 55 | |||||||||||
| (1) | Second quarter 2021 results include incremental expenses attributable to the first quarter 2021 general and administrative expenses following a refinement made to the allocation of expenses in the second quarter of 2021, which increased the general and administrative expenses of the Run-off segment for the three months ended June 30, 2021 by $16 million. |
Three and Six Months Ended June 30, 2022 versus 2021: Net earnings from our Run-off segment increased by $69 million and $55 million, respectively, primarily due to:
- A $62 million and $73 million increase in favorable PPD for the three and six months ended June 30, 2022, respectively, driven by a $66 million and $70 million increase in the reduction in estimates of net ultimate losses, respectively, primarily due to favorable loss activity in the professional indemnity/directors and officers and workers’ compensation lines of business; and
- A decrease in general and administrative expenses of $28 million and $17 million, respectively. Excluding the impact of the refinement made to the allocation of expenses in the second quarter of 2021 as described above, these decreases were primarily driven by lower salaries and benefits due to reductions in head count and long-term incentive plan costs and decreases in professional fees for the three and six months ended June 30, 2022; partially offset by
- Reductions in net premiums earned that were greater than the reductions in current period net incurred losses and LAE for the three and six months ended June 30, 2022, following our exit of our StarStone International business beginning in 2020; and
- A reduction in other income of $7 million and $19 million, respectively, primarily driven by lower favorable prior period development related to our defendant A&E liabilities for the three and six months ended June 30, 2022.
Investments Segment
The following is a discussion and analysis of the results of operations for our Investments segment.
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| June 30, | $ | June 30, | $ | ||||||||||||||||||||
| 2022 | 2021 | Change | 2022 | 2021 | Change | ||||||||||||||||||
| (in millions of U.S. dollars) | |||||||||||||||||||||||
| INCOME | |||||||||||||||||||||||
| Net investment income: | |||||||||||||||||||||||
| Fixed income securities | $ | 85 | $ | 87 | $ | (2 | ) | $ | 153 | $ | 138 | $ | 15 | ||||||||||
| Cash and restricted cash | 1 | — | 1 | 1 | — | 1 | |||||||||||||||||
| Other investments, including equities | 22 | 15 | 7 | 41 | 29 | 12 | |||||||||||||||||
| Less: Investment expenses | (4 | ) | (26 | ) | 22 | (15 | ) | (30 | ) | 15 | |||||||||||||
| Total net investment income | 104 | 76 | 28 | 180 | 137 | 43 | |||||||||||||||||
| Net realized (losses) gains: | |||||||||||||||||||||||
| Fixed income securities | (30 | ) | 5 | (35 | ) | (65 | ) | (6 | ) | (59 | ) | ||||||||||||
| Other investments, including equities | (8 | ) | 1 | (9 | ) | (10 | ) | 2 | (12 | ) | |||||||||||||
| Net realized (losses) gains: | (38 | ) | 6 | (44 | ) | (75 | ) | (4 | ) | (71 | ) | ||||||||||||
| Net unrealized (losses) gains: | |||||||||||||||||||||||
| Fixed income securities | (377 | ) | 105 | (482 | ) | (670 | ) | (89 | ) | (581 | ) | ||||||||||||
| Other investments, including equities | (212 | ) | 295 | (507 | ) | (294 | ) | 479 | (773 | ) | |||||||||||||
| Total net unrealized (losses) gains: | (589 | ) | 400 | (989 | ) | (964 | ) | 390 | (1,354 | ) | |||||||||||||
| Total income | (523 | ) | 482 | (1,005 | ) | (859 | ) | 523 | (1,382 | ) | |||||||||||||
| EXPENSES | |||||||||||||||||||||||
| General and administrative expenses (1) | 10 | 13 | (3 | ) | 19 | 16 | 3 | ||||||||||||||||
| Total expenses | 10 | 13 | (3 | ) | 19 | 16 | 3 | ||||||||||||||||
| Earnings (losses) from equity method investments | 1 | (3 | ) | 4 | 32 | 115 | (83 | ) | |||||||||||||||
| SEGMENT NET (LOSS) EARNINGS | $ | (532 | ) | $ | 466 | $ | (998 | ) | $ | (846 | ) | $ | 622 | $ | (1,468 | ) | |||||||
| (1) | Second quarter 2021 results include incremental expenses attributable to the first quarter 2021 general and administrative expenses following a refinement made to the allocation of expenses in the second quarter of 2021, which increased the general and administrative expenses of the Investments segment for the three months ended June 30, 2021 by $3 million. |
Three and Six Months Ended June 30, 2022 versus 2021: Net loss from our Investments segment was $532 million and $846 million for the three and six months ended June 30, 2022, respectively, compared to net earnings of $466 million and $622 million for the three and six months ended June 30, 2021. The unfavorable movements of $998 million and $1.5 billion, respectively, were primarily due to:
- net realized and unrealized losses on our fixed income securities of $407 million and $735 million, respectively, driven by rising interest rates and widening credit spreads, in comparison to net gains of $110 million and net losses of $95 million, respectively, in the comparative periods;
- net realized and unrealized losses on our other investments, including equities, of $220 million and $304 million, respectively, in comparison to net gains of $296 million and $481 million, respectively, in the comparative periods, primarily driven by underperformance of our fixed income funds, public equities and CLO equities as a result of significant volatility in global equity markets and widening high yield credit spreads. The results were partially offset by gains on our private equity funds, private credit funds and real estate funds, which are typically recorded on a one quarter lag, and net gains on our hedge funds for the three months ended June 30, 2022 as a result of exposure to Chinese equities; and
- an $83 million decrease in earnings from equity method investments for the six months ended June 30, 2022, largely due to our acquisition of the controlling interest in Enhanzed Re, effective September 1, 2021 (consolidated net loss from Enhanzed Re was $95 million for the six months ended June 30, 2022). Prior to that date, the results of Enhanzed Re were recorded in earnings from equity method investments within the Investments segment; partially offset by:
- increases in our net investment income of $28 million and $43 million, respectively, which is primarily due to an increase in our average aggregate fixed income assets due to new business during the past year and the reinvestment of fixed maturities at higher yields.
Net investment losses recognized on the fixed income securities that support our Enhanzed Re life reinsurance business for the three and six months ended June 30, 2022 were $109 million and $128 million, respectively.
Income and Earnings by Segment - For the Three and Six Months Ended June 30, 2022 and 2021
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| June 30, 2022 | June 30, 2021 | $ Change | June 30, 2022 | June 30, 2021 | $ Change | ||||||||||||||||||
| (in millions of U.S. dollars) | |||||||||||||||||||||||
| INCOME | |||||||||||||||||||||||
| Run-off | $ | 16 | $ | 56 | $ | (40 | ) | $ | 43 | $ | 151 | $ | (108 | ) | |||||||||
| Enhanzed Re | 1 | — | 1 | 15 | — | 15 | |||||||||||||||||
| Investments | (523 | ) | 482 | (1,005 | ) | (859 | ) | 523 | (1,382 | ) | |||||||||||||
| Legacy Underwriting | 6 | 15 | (9 | ) | 8 | 28 | (20 | ) | |||||||||||||||
| Subtotal | (500 | ) | 553 | (1,053 | ) | (793 | ) | 702 | (1,495 | ) | |||||||||||||
| Corporate and other | 14 | (6 | ) | 20 | 17 | 4 | 13 | ||||||||||||||||
| Total income | $ | (486 | ) | $ | 547 | $ | (1,033 | ) | $ | (776 | ) | $ | 706 | $ | (1,482 | ) | |||||||
| SEGMENT NET (LOSS) EARNINGS | |||||||||||||||||||||||
| Run-off (3) | $ | 78 | $ | 9 | $ | 69 | $ | 97 | $ | 42 | $ | 55 | |||||||||||
| Enhanzed Re | (7 | ) | — | (7 | ) | 22 | — | 22 | |||||||||||||||
| Investments (3) | (532 | ) | 466 | (998 | ) | (846 | ) | 622 | (1,468 | ) | |||||||||||||
| Legacy Underwriting | — | (2 | ) | 2 | — | — | — | ||||||||||||||||
| Total segment net (loss) earnings | (461 | ) | 473 | (934 | ) | (727 | ) | 664 | (1,391 | ) | |||||||||||||
| Corporate and other (1)(2)(3) | (32 | ) | (95 | ) | 63 | (48 | ) | (103 | ) | 55 | |||||||||||||
| NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS | $ | (493 | ) | $ | 378 | $ | (871 | ) | $ | (775 | ) | $ | 561 | $ | (1,336 | ) | |||||||
| (1) | Other income (expense) for corporate and other activities includes the amortization of fair value adjustments associated with the acquisition of DCo LLC and Morse TEC LLC. |
| (2) | Net incurred losses and LAE for corporate and other activities includes the amortization of deferred charge assets (“DCAs”) on retroactive reinsurance contracts, fair value adjustments associated with the acquisition of companies and the changes in the discount rate and risk margin components of the fair value of assets and liabilities related to our assumed retroactive reinsurance contracts for which we have elected the fair value option. The three and six months ended June 30, 2022 included accelerated amortization of $72 million and $96 million, respectively, corresponding to increased favorable prior period development on net ultimate liabilities recorded in our Run-off segment. The three and six months ended June 30, 2021 included accelerated amortization of $11 million corresponding to increased favorable prior period development on net ultimate liabilities recorded in our Run-off segment. |
| (3) | Second quarter 2021 results include incremental expenses attributable to the first quarter 2021 general and administrative expenses following a refinement made to the allocation of expenses in the second quarter of 2021, which increased/(decreased) general and administrative expenses of the Run-off and Investment segments by $16 million and $3 million, respectively, as well as corporate and other activities by $(19) million, for the three months ended June 30, 2021. |
For additional detail on the Enhanzed Re segment, the Legacy Underwriting segment and corporate and other activities, please refer to the Form 10-Q.
Cautionary Statement
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding the intent, belief or current expectations of Enstar and its management team. Investors are cautioned that any such forward-looking statements speak only as of the date they are made, are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Important risk factors regarding Enstar can be found under the heading "Risk Factors" in our Form 10-K for the year ended December 31, 2021 and are incorporated herein by reference. Furthermore, Enstar undertakes no obligation to update any written or oral forward-looking statements or publicly announce any updates or revisions to any of the forward-looking statements contained herein, to reflect any change in its expectations with regard thereto or any change in events, conditions, circumstances or assumptions underlying such statements, except as required by law.
About Enstar
Enstar is a NASDAQ-listed leading global (re)insurance group that offers capital release solutions through its network of group companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and other international locations. A market leader in completing legacy acquisitions, Enstar has acquired over 110 companies and portfolios since its formation in 2001. For further information about Enstar, see www.enstargroup.com.
Contacts
For Investors: Matthew Kirk (investor.relations@enstargroup.com)
For Media: Jenna Kerr (communications@enstargroup.com)
ENSTAR GROUP LIMITED
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)
For the Three and Six Months Ended June 30, 2022 and 2021
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||
| (expressed in millions of U.S. dollars, except share and per share data) | |||||||||||||||
| INCOME | |||||||||||||||
| Net premiums earned | $ | 14 | $ | 59 | $ | 48 | $ | 152 | |||||||
| Net investment income | 106 | 76 | 186 | 138 | |||||||||||
| Net realized (losses) gains | (38 | ) | 6 | (75 | ) | (5 | ) | ||||||||
| Net unrealized (losses) gains | (591 | ) | 400 | (972 | ) | 390 | |||||||||
| Other income | 23 | 6 | 37 | 16 | |||||||||||
| Net gain on sales of subsidiaries | — | — | — | 15 | |||||||||||
| Total income | (486 | ) | 547 | (776 | ) | 706 | |||||||||
| EXPENSES | |||||||||||||||
| Net incurred losses and loss adjustment expenses | |||||||||||||||
| Current period | 13 | 50 | 26 | 104 | |||||||||||
| Prior periods | (79 | ) | (10 | ) | (222 | ) | (120 | ) | |||||||
| Total net incurred losses and loss adjustment expenses | (66 | ) | 40 | (196 | ) | (16 | ) | ||||||||
| Policyholder benefit expenses | 6 | — | 18 | — | |||||||||||
| Acquisition costs | 12 | 5 | 20 | 39 | |||||||||||
| General and administrative expenses | 83 | 93 | 168 | 176 | |||||||||||
| Interest expense | 23 | 17 | 48 | 33 | |||||||||||
| Net foreign exchange (gains) | (13 | ) | (10 | ) | (10 | ) | (7 | ) | |||||||
| Total expenses | 45 | 145 | 48 | 225 | |||||||||||
| (LOSS) EARNINGS BEFORE INCOME TAXES | (531 | ) | 402 | (824 | ) | 481 | |||||||||
| Income tax benefit (expense) | 4 | (9 | ) | 4 | (3 | ) | |||||||||
| Earnings (losses) from equity method investments | 1 | (3 | ) | 32 | 115 | ||||||||||
| NET (LOSS) EARNINGS | (526 | ) | 390 | (788 | ) | 593 | |||||||||
| Net loss (earnings) attributable to noncontrolling interests | 42 | (3 | ) | 31 | (14 | ) | |||||||||
| NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR | (484 | ) | 387 | (757 | ) | 579 | |||||||||
| Dividends on preferred shares | (9 | ) | (9 | ) | (18 | ) | (18 | ) | |||||||
| NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS | $ | (493 | ) | $ | 378 | $ | (775 | ) | $ | 561 | |||||
| (Loss) earnings per ordinary share attributable to Enstar: | |||||||||||||||
| Basic | $ | (28.62 | ) | $ | 17.44 | $ | (44.54 | ) | $ | 25.95 | |||||
| Diluted | $ | (28.62 | ) | $ | 17.28 | $ | (44.54 | ) | $ | 25.60 | |||||
| Weighted average ordinary shares outstanding: | |||||||||||||||
| Basic | 17,224,449 | 21,631,749 | 17,400,257 | 21,597,236 | |||||||||||
| Diluted | 17,470,691 | 21,832,218 | 17,634,698 | 21,892,744 | |||||||||||
ENSTAR GROUP LIMITED
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
As of June 30, 2022 and December 31, 2021
| June 30, 2022 | December 31, 2021 | ||||||
| (in millions of U.S. dollars, except share data) | |||||||
| ASSETS | |||||||
| Short-term investments, trading, at fair value | $ | 15 | $ | 6 | |||
| Short-term investments, available-for-sale, at fair value (amortized cost: 2022 — $43; 2021 — $34; net of allowance: 2022 and 2021 — $0) | 42 | 34 | |||||
| Fixed maturities, trading, at fair value | 2,783 | 3,756 | |||||
| Fixed maturities, available-for-sale, at fair value (amortized cost: 2022 — $5,673; 2021 — $5,689; net of allowance: 2022 — $42; 2021 — $10) | 5,099 | 5,652 | |||||
| Funds held - directly managed | 2,481 | 3,007 | |||||
| Equities, at fair value (cost: 2022 — $1,819; 2021 — $1,831) | 1,776 | 1,995 | |||||
| Other investments, at fair value | 3,125 | 2,333 | |||||
| Equity method investments | 506 | 493 | |||||
| Total investments | 15,827 | 17,276 | |||||
| Cash and cash equivalents | 785 | 1,646 | |||||
| Restricted cash and cash equivalents | 301 | 446 | |||||
| Reinsurance balances recoverable on paid and unpaid losses (net of allowance: 2022 — $137; 2021 — $136) | 948 | 1,085 | |||||
| Reinsurance balances recoverable on paid and unpaid losses, at fair value | 327 | 432 | |||||
| Insurance balances recoverable (net of allowance: 2022 and 2021 — $5) | 191 | 213 | |||||
| Funds held by reinsured companies | 3,956 | 2,340 | |||||
| Deferred charge assets | 286 | 371 | |||||
| Other assets | 648 | 620 | |||||
| TOTAL ASSETS | $ | 23,269 | $ | 24,429 | |||
| LIABILITIES | |||||||
| Losses and loss adjustment expenses | $ | 12,142 | $ | 11,269 | |||
| Losses and loss adjustment expenses, at fair value | 1,499 | 1,989 | |||||
| Future policyholder benefits | 1,363 | 1,502 | |||||
| Defendant asbestos and environmental liabilities | 620 | 638 | |||||
| Insurance and reinsurance balances payable | 205 | 254 | |||||
| Debt obligations | 1,905 | 1,691 | |||||
| Other liabilities | 475 | 581 | |||||
| TOTAL LIABILITIES | 18,209 | 17,924 | |||||
| COMMITMENTS AND CONTINGENCIES | |||||||
| REDEEMABLE NONCONTROLLING INTERESTS | 174 | 179 | |||||
| SHAREHOLDERS’ EQUITY | |||||||
| Ordinary Shares (par value $1 each, issued and outstanding 2022: 17,574,197; 2021: 18,223,574): | |||||||
| Voting Ordinary Shares (issued and outstanding 2022: 15,976,485; 2021: 16,625,862) | 16 | 17 | |||||
| Non-voting convertible ordinary Series C Shares (issued and outstanding 2022 and 2021: 1,192,941) | 1 | 1 | |||||
| Non-voting convertible ordinary Series E Shares (issued and outstanding 2022 and 2021: 404,771) | — | — | |||||
| Preferred Shares: | |||||||
| Series C Preferred Shares (issued and held in treasury 2022 and 2021: 388,571) | — | — | |||||
| Series D Preferred Shares (issued and outstanding 2022 and 2021: 16,000; liquidation preference $400) | 400 | 400 | |||||
| Series E Preferred Shares (issued and outstanding 2022 and 2021: 4,400; liquidation preference $110) | 110 | 110 | |||||
| Treasury shares, at cost (Series C Preferred Shares 2022 and 2021: 388,571) | (422 | ) | (422 | ) | |||
| Joint Share Ownership Plan (voting ordinary shares, held in trust 2022 and 2021: 565,630) | (1 | ) | (1 | ) | |||
| Additional paid-in capital | 769 | 922 | |||||
| Accumulated other comprehensive loss | (490 | ) | (16 | ) | |||
| Retained earnings | 4,310 | 5,085 | |||||
| Total Enstar Shareholders’ Equity | 4,693 | 6,096 | |||||
| Noncontrolling interests | 193 | 230 | |||||
| TOTAL SHAREHOLDERS’ EQUITY | 4,886 | 6,326 | |||||
| TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND SHAREHOLDERS’ EQUITY | $ | 23,269 | $ | 24,429 | |||
Non-GAAP Financial Measures
In addition to our key financial measures presented in accordance with GAAP, we present other non-GAAP financial measures that we use to manage our business, compare our performance against prior periods and against our peers, and as performance measures in our incentive compensation program.
These non-GAAP financial measures provide an additional view of our operational performance over the long-term and provide the opportunity to analyze our results in a way that is more aligned with the manner in which our management measures our underlying performance.
The presentation of these non-GAAP financial measures, which may be defined and calculated differently by other companies, is used to enhance the understanding of certain aspects of our financial performance. It is not meant to be considered in isolation, superior to, or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.
We have presented the results and GAAP reconciliations for these measures further below. The following tables present more information on each non-GAAP measure.
| Non-GAAP Measure | Definition | Purpose of Non-GAAP Measure over GAAP Measure | ||
| Adjusted book value per ordinary share | Total Enstar ordinary shareholders' equity Divided by Number of ordinary shares outstanding, adjusted for: -the ultimate effect of any dilutive securities on the number of ordinary shares outstanding | Increases the number of ordinary shares to reflect equity awards granted but not yet vested as, over the long term, this presents a prudent view of our book value per share. We use this non-GAAP measure in our incentive compensation program. | ||
| Adjusted return on equity (%) | Adjusted operating income (loss) attributable to Enstar ordinary shareholders divided by adjusted opening Enstar ordinary shareholder's equity | Calculating the operating income (loss) as a percentage of our adjusted opening Enstar ordinary shareholders' equity provides a more valuable and consistent measure of the performance of our business, and enhances comparisons to prior periods:
We include the amortization of fair value adjustments as a non-GAAP adjustment to the adjusted operating income (loss) attributable to Enstar ordinary shareholders as it is considered to be a non-cash charge and not indicative of our operating results. | ||
| Adjusted operating income (loss) attributable to Enstar ordinary shareholders (numerator) | Net earnings (loss) attributable to Enstar ordinary shareholders, adjusted for: -net realized and unrealized (gains) losses on fixed maturity investments and funds held-directly managed -change in fair value of insurance contracts for which we have elected the fair value option (1) -amortization of fair value adjustments -net gain/loss on purchase and sales of subsidiaries (if any) -net earnings from discontinued operations (if any) -tax effects of adjustments -adjustments attributable to noncontrolling interests | |||
| Adjusted opening Enstar ordinary shareholders' equity (denominator) | Opening Enstar ordinary shareholders' equity, less: -net unrealized gains (losses) on fixed maturity investments and funds held-directly managed, -fair value of insurance contracts for which we have elected the fair value option (1), -fair value adjustments, and -net assets of held for sale or disposed subsidiaries classified as discontinued operations (if any) | |||
| Adjusted total investment return (%) | Adjusted total investment return (dollars) recognized in earnings for the applicable period divided by period average adjusted total investable assets. | Provides a key measure of the return generated on the capital held in the business and is reflective of our investment strategy. Provides a consistent measure of investment returns as a percentage of all assets generating investment returns. Adjusts investment returns for the temporary impact of the change in fair value of fixed maturity securities (both credit spreads and interest rates) which we hold until the earlier of maturity or used to fund any settlement of related liabilities which are generally recorded at cost. | ||
| Adjusted total investment return ($) (numerator) | Total investment return (dollars), adjusted for: -net realized and unrealized (gains) losses on fixed maturity investments and funds held-directly managed | |||
| Adjusted average aggregate total investable assets (denominator) | Total average investable assets, adjusted for: -net unrealized (gains) losses on fixed maturities, AFS investments included within AOCI -net unrealized (gains) losses on fixed maturities, trading instruments | |||
| Adjusted run-off liability earnings (%) | Adjusted PPD divided by average adjusted net loss reserves | Calculating the RLE as a percentage of our adjusted average net loss reserves provides a more meaningful measurement of our claims management performance. We use this measure to evaluate our ability to settle our obligations for amounts less than our initial estimate at the point of acquiring the obligations. In order to provide a complete and consistent picture of our claims performance, we combine the reduction (increase) in estimates of prior period net ultimate losses relating to our Run-off segment with the amortization of deferred charge assets, both of which are included in net incurred losses and LAE and have an inverse effect on our results. We also include our performance in managing our defendant A&E liabilities, that do not form part of loss reserves. The remaining components of net incurred losses and LAE and net loss reserves are not considered key components of our claims performance as they are either not non-life run-off in nature, or are considered to be non-cash charges that obscure our trends on a consistent basis. We use this measure to assess the performance of our claim strategies and part of the performance assessment of our past acquisitions. | ||
| Adjusted prior period development (numerator) | Prior period net incurred losses and LAE, adjusted to: Remove: -Legacy Underwriting and Enhanzed Re operations -the reduction/(increase) in provisions for unallocated LAE (ULAE) -amortization of fair value adjustments, -change in fair value of insurance contracts for which we have elected the fair value option (1), and Add: -the reduction/(increase) in estimates of our defendant A&E ultimate net liabilities. | |||
| Adjusted net loss reserves (denominator) | Net losses and LAE, adjusted to: Remove: -Legacy Underwriting and Enhanzed Re net loss reserves -current period net loss reserves -the net ULAE provision -net fair value adjustments associated with the acquisition of companies, -the fair value adjustments for contracts for which we have elected the fair value option (1) and Add: -net nominal defendant asbestos and environmental exposures. |
(1) Comprises the discount rate and risk margin components.
Reconciliation of GAAP to Non-GAAP Measures
The table below presents a reconciliation of BVPS to Adjusted BVPS*:
| June 30, 2022 | December 31, 2021 | ||||||||||||||
| Equity (1) | Ordinary Shares | Per Share Amount | Equity (1) | Ordinary Shares | Per Share Amount | ||||||||||
| (in millions of U.S. dollars, except share and per share data) | |||||||||||||||
| Book value per ordinary share | $ | 4,183 | 17,008,567 | $ | 245.93 | $ | 5,586 | 17,657,944 | $ | 316.34 | |||||
| Non-GAAP adjustments: | |||||||||||||||
| Share-based compensation plans | 344,890 | 315,205 | |||||||||||||
| Adjusted book value per ordinary share* | $ | 4,183 | 17,353,457 | $ | 241.05 | $ | 5,586 | 17,973,149 | $ | 310.80 | |||||
(1) Equity comprises Enstar ordinary shareholders' equity, which is calculated as Enstar shareholders' equity less preferred shares ($510 million) prior to any non-GAAP adjustments.
The tables below present a reconciliation of Annualized ROE to Annualized Adjusted ROE*:
| Three Months Ended | |||||||||||||||||||||||||
| June 30, 2022 | June 30, 2021 | ||||||||||||||||||||||||
| Net (loss) earnings (1) | Opening equity (1) | (Adj) ROE | Annualized (Adj) ROE | Net (loss) earnings (1) | Opening equity (1) | (Adj) ROE | Annualized (Adj) ROE | ||||||||||||||||||
| (in millions of U.S. dollars) | |||||||||||||||||||||||||
| Net (loss) earnings/Opening equity/ROE/Annualized ROE (1) | $ | (493 | ) | $ | 5,024 | (9.8)% | (39.3)% | $ | 378 | $ | 6,251 | 6.0 | % | 24.2 | % | ||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||
| Remove: | |||||||||||||||||||||||||
| Net realized and unrealized losses (gains) on fixed maturity investments and funds held - directly managed / Net unrealized losses (gains) on fixed maturity investments and funds held - directly managed (2) | 409 | 458 | (110 | ) | (228 | ) | |||||||||||||||||||
| Change in fair value of insurance contracts for which we have elected the fair value option / Fair value of insurance contracts for which we have elected the fair value option (3) | (48 | ) | (201 | ) | 17 | (109 | ) | ||||||||||||||||||
| Amortization of fair value adjustments / Fair value adjustments | 5 | (104 | ) | 6 | (125 | ) | |||||||||||||||||||
| Tax effects of adjustments (4) | 20 | 4 | |||||||||||||||||||||||
| Adjustments attributable to noncontrolling interests (5) | (43 | ) | 1 | ||||||||||||||||||||||
| Adjusted operating (loss) income/Adjusted opening equity/Adjusted ROE/Annualized adjusted ROE* | $ | (150 | ) | $ | 5,177 | (2.9)% | (11.6)% | $ | 296 | $ | 5,789 | 5.1 | % | 20.5 | % | ||||||||||
| (1) | Net (loss) earnings comprises net (loss) earnings attributable to Enstar ordinary shareholders, prior to any non-GAAP adjustments. Opening equity comprises Enstar ordinary shareholders' equity, which is calculated as opening Enstar shareholders' equity less preferred shares ($510 million), prior to any non-GAAP adjustments. |
| (2) | Represents the net realized and unrealized losses (gains) related to fixed maturity securities. Our fixed maturity securities are held directly on our balance sheet and also within the "Funds held - directly managed" balance. |
| (3) | Comprises the discount rate and risk margin components. |
| (4) | Represents an aggregation of the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates, calculated at the applicable jurisdictional tax rate. |
| (5) | Represents the impact of the adjustments on the net earnings (loss) attributable to noncontrolling interests associated with the specific subsidiaries to which the adjustments relate. |
*Non-GAAP measure.
| Six Months Ended | |||||||||||||||||||||||||
| June 30, 2022 | June 30, 2021 | ||||||||||||||||||||||||
| Net (loss) earnings (1) | Opening equity (1) | (Adj) ROE | Annualized (Adj) ROE | Net (loss) earnings (1) | Opening equity (1) | (Adj) ROE | Annualized (Adj) ROE | ||||||||||||||||||
| (in millions of U.S. dollars) | |||||||||||||||||||||||||
| Net (loss) earnings/Opening equity/ROE/Annualized ROE (1) | $ | (775 | ) | $ | 5,586 | (13.9)% | (27.7)% | $ | 561 | $ | 6,164 | 9.1 | % | 18.2 | % | ||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||
| Net realized and unrealized losses on fixed maturity investments and funds held - directly managed / Net unrealized gains on fixed maturity investments and funds held - directly managed (2) | 743 | (89 | ) | 96 | (560 | ) | |||||||||||||||||||
| Change in fair value of insurance contracts for which we have elected the fair value option / Fair value of insurance contracts for which we have elected the fair value option (3) | (146 | ) | (107 | ) | (58 | ) | (33 | ) | |||||||||||||||||
| Amortization of fair value adjustments / Fair value adjustments | 7 | (106 | ) | 8 | (128 | ) | |||||||||||||||||||
| Net gain on sales of subsidiaries | — | (15 | ) | ||||||||||||||||||||||
| Tax effects of adjustments (4) | (4 | ) | (13 | ) | |||||||||||||||||||||
| Adjustments attributable to noncontrolling interests (5) | (48 | ) | 12 | ||||||||||||||||||||||
| Adjusted operating (loss) income/Adjusted opening equity/Adjusted ROE/Annualized adjusted ROE* | $ | (223 | ) | $ | 5,284 | (4.2)% | (8.4)% | $ | 591 | $ | 5,443 | 10.9 | % | 21.7 | % | ||||||||||
| (1) | Net (loss) earnings comprises net (loss) earnings attributable to Enstar ordinary shareholders, prior to any non-GAAP adjustments. Opening equity comprises Enstar ordinary shareholders' equity, which is calculated as opening Enstar shareholders' equity less preferred shares ($510 million), prior to any non-GAAP adjustments. |
| (2) | Represents the net realized and unrealized losses (gains) related to fixed maturity securities. Our fixed maturity securities are held directly on our balance sheet and also within the "Funds held - directly managed" balance. |
| (3) | Comprises the discount rate and risk margin components. |
| (4) | Represents an aggregation of the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates, calculated at the applicable jurisdictional tax rate. |
| (5) | Represents the impact of the adjustments on the net earnings (loss) attributable to noncontrolling interests associated with the specific subsidiaries to which the adjustments relate. |
*Non-GAAP measure.
The tables below present a reconciliation of PPD to Adjusted PPD* and Annualized RLE to Annualized Adjusted RLE*:
| Three Months Ended | As of | Three Months Ended | ||||||||||||||||
| June 30, 2022 | June 30, 2022 | March 31, 2022 | June 30, 2022 | June 30, 2022 | ||||||||||||||
| PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | ||||||||||||||
| (in millions of U.S. dollars) | ||||||||||||||||||
| PPD/net loss reserves/Annualized RLE | $ | 79 | $ | 12,238 | $ | 10,962 | $ | 11,600 | 2.7 | % | ||||||||
| Non-GAAP Adjustments: | ||||||||||||||||||
| Enhanzed Re | (1 | ) | (147 | ) | (150 | ) | (149 | ) | ||||||||||
| Legacy Underwriting | 6 | (140 | ) | (142 | ) | (141 | ) | |||||||||||
| Net loss reserves - current period | — | (26 | ) | (13 | ) | (20 | ) | |||||||||||
| Reduction in provisions for ULAE / Net ULAE provisions | (13 | ) | (504 | ) | (394 | ) | (449 | ) | ||||||||||
| Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 5 | 99 | 104 | 102 | ||||||||||||||
| Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option (1) | (48 | ) | 239 | 201 | 220 | |||||||||||||
| Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 1 | 574 | 586 | 580 | ||||||||||||||
| Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 29 | $ | 12,333 | $ | 11,154 | $ | 11,743 | 1.0 | % | ||||||||
| Three Months Ended | As of | Three Months Ended | ||||||||||||||||
| June 30, 2021 | June 30, 2021 | March 31, 2021 | June 30, 2021 | June 30, 2021 | ||||||||||||||
| PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | ||||||||||||||
| (in millions of U.S. dollars) | ||||||||||||||||||
| PPD/net loss reserves/Annualized RLE | $ | 10 | $ | 10,835 | $ | 9,215 | $ | 10,025 | 0.4 | % | ||||||||
| Non-GAAP Adjustments: | ||||||||||||||||||
| Legacy Underwriting | 4 | (156 | ) | (153 | ) | (155 | ) | |||||||||||
| Net loss reserves - current period | — | (91 | ) | (48 | ) | (70 | ) | |||||||||||
| Reduction in provisions for ULAE / Net ULAE provisions | (18 | ) | (410 | ) | (396 | ) | (403 | ) | ||||||||||
| Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 6 | 120 | 125 | 123 | ||||||||||||||
| Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option (1) | 17 | 91 | 109 | 100 | ||||||||||||||
| Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 5 | 584 | 599 | 592 | ||||||||||||||
| Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 24 | $ | 10,973 | $ | 9,451 | $ | 10,212 | 0.9 | % | ||||||||
(1) Comprises the discount rate and risk margin components.
*Non-GAAP measure.
| Six Months Ended | As of | Six Months Ended | ||||||||||||||||
| June 30, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2022 | June 30, 2022 | ||||||||||||||
| PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | ||||||||||||||
| (in millions of U.S. dollars) | ||||||||||||||||||
| PPD/net loss reserves/Annualized RLE | $ | 222 | $ | 12,238 | $ | 11,555 | $ | 11,897 | 3.7 | % | ||||||||
| Non-GAAP Adjustments: | ||||||||||||||||||
| Enhanzed Re | (29 | ) | (147 | ) | (181 | ) | (164 | ) | ||||||||||
| Legacy Underwriting | 5 | (140 | ) | (153 | ) | (147 | ) | |||||||||||
| Net loss reserves - current period | — | (26 | ) | — | (13 | ) | ||||||||||||
| Reduction in provisions for ULAE / Net ULAE provisions | (35 | ) | (504 | ) | (416 | ) | (460 | ) | ||||||||||
| Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 7 | 99 | 106 | 103 | ||||||||||||||
| Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option (1) | (146 | ) | 239 | 107 | 173 | |||||||||||||
| Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 4 | 574 | 574 | 574 | ||||||||||||||
| Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 28 | $ | 12,333 | $ | 11,592 | $ | 11,963 | 0.5 | % | ||||||||
| Six Months Ended | As of | Six Months Ended | ||||||||||||||||
| June 30, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2021 | June 30, 2021 | ||||||||||||||
| PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | ||||||||||||||
| (in millions of U.S. dollars) | ||||||||||||||||||
| PPD/net loss reserves/Annualized RLE | $ | 120 | $ | 10,835 | $ | 8,544 | $ | 9,690 | 2.5 | % | ||||||||
| Non-GAAP Adjustments: | ||||||||||||||||||
| Legacy Underwriting | (2 | ) | (156 | ) | (955 | ) | (556 | ) | ||||||||||
| Net loss reserves - current period | — | (91 | ) | — | (46 | ) | ||||||||||||
| Reduction in provisions for ULAE / Net ULAE provisions | (32 | ) | (410 | ) | (334 | ) | (372 | ) | ||||||||||
| Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 8 | 120 | 128 | 124 | ||||||||||||||
| Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option (1) | (58 | ) | 91 | 33 | 62 | |||||||||||||
| Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 14 | 584 | 615 | 600 | ||||||||||||||
| Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 50 | $ | 10,973 | $ | 8,031 | $ | 9,502 | 1.1 | % | ||||||||
(1) Comprises the discount rate and risk margin components.
*Non-GAAP measure.
The tables below present a reconciliation of our Annualized TIR to our Annualized Adjusted TIR*:
| Three Months Ended | Six Months Ended | ||||||||||||||
| June 30, 2022 | June 30, 2021 | June 30, 2022 | June 30, 2021 | ||||||||||||
| (in millions of U.S. dollars) | |||||||||||||||
| Net investment income | $ | 106 | $ | 76 | $ | 186 | $ | 138 | |||||||
| Net realized (losses) gains | (38 | ) | 6 | (75 | ) | (5 | ) | ||||||||
| Net unrealized (losses) gains | (591 | ) | 400 | (972 | ) | 390 | |||||||||
| Earnings (losses) from equity method investments | 1 | (3 | ) | 32 | 115 | ||||||||||
| TIR ($) | $ | (522 | ) | $ | 479 | $ | (829 | ) | $ | 638 | |||||
| Non-GAAP adjustment: | |||||||||||||||
| Net realized and unrealized losses (gains) on fixed maturity investments and funds held-directly managed | 409 | (110 | ) | 743 | 96 | ||||||||||
| Adjusted TIR ($)* | $ | (113 | ) | $ | 369 | $ | (86 | ) | $ | 734 | |||||
| Total investments | $ | 15,827 | $ | 14,621 | $ | 15,827 | $ | 14,621 | |||||||
| Cash and cash equivalents, including restricted cash and cash equivalents | 1,086 | 1,126 | 1,086 | 1,126 | |||||||||||
| Funds held by reinsured companies | 3,956 | 2,202 | 3,956 | 2,202 | |||||||||||
| Net variable interest entity assets | — | 2,220 | — | 2,220 | |||||||||||
| Total investable assets | $ | 20,869 | $ | 20,169 | $ | 20,869 | $ | 20,169 | |||||||
| Average aggregate invested assets, at fair value (1) | 19,826 | 19,176 | 20,464 | 18,636 | |||||||||||
| Annualized TIR % (2) | (10.5 | )% | 10.0 | % | (8.1 | )% | 6.8 | % | |||||||
| Non-GAAP adjustment: | |||||||||||||||
| Net unrealized losses (gains) on fixed maturities, AFS investments included within AOCI and net unrealized losses (gains) on fixed maturities, trading instruments | 1,246 | (339 | ) | 1,246 | (339 | ) | |||||||||
| Adjusted investable assets* | $ | 22,115 | $ | 19,830 | $ | 22,115 | $ | 19,830 | |||||||
| Adjusted average aggregate invested assets, at fair value* (3) | $ | 20,711 | $ | 18,896 | $ | 21,024 | $ | 18,260 | |||||||
| Annualized adjusted TIR %* (4) | (2.2 | )% | 7.8 | % | (0.8 | )% | 8.0 | % | |||||||
| (1) | This amount is a two and three period average of the total investable assets for the three and six months ended June 30, 2022 and 2021, respectively, as presented above, and is comprised of amounts disclosed in our quarterly and annual U.S. GAAP consolidated financial statements. |
| (2) | Annualized TIR % is calculated by dividing the annualized TIR ($) by average aggregate invested assets, at fair value. |
| (3) | This amount is a two and three period average of the adjusted investable assets* for the three and six months ended June 30, 2022 and 2021, respectively, as presented above. |
| (4) | Annualized adjusted TIR %* is calculated by dividing the annualized adjusted TIR* ($) by adjusted average aggregate invested assets, at fair value*. |
*Non-GAAP measure.
